Armenian Hamster IgG2 Isotype Control
IsoC, ELISA, CyTox, BR, CoSt
B81-3
IgG2
unconjugated
(1 reference)-
- Target See all IgG2 products
- IgG2
-
Host
- Armenian Hamster
- Application
- Isotype Control (IsoC), ELISA, Cytotoxicity Test (CyTox), Blocking Reagent (BR), Co-Stimulation (CoSt)
- Brand
- BD Pharmingen™
- Characteristics
- The B81-3 monoclonal antibody is specific for keyhole limpet hemocyanin (KLH), an antigen not expressed by mammalian cells or cell lines.
- Purification
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
- Sterility
- 0.2 μm filtered
- Endotoxin Level
- Endotoxin level is ≤0.01 EU/μg (≤0.001 ng/μg) of protein as determined by the LAL assay.
- Immunogen
- Keyhole Limpet Hemocyanin
-
Clone
- B81-3
- Isotype
- IgG2
-
HEK-293 Cells IgG2 isotype control
IsoC IgG2 unconjugated
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.0 mg/mL
- Buffer
- No azide/low endotoxin: Aqueous buffered solution containing no preservative
- Preservative
- Azide free
- Storage
- 4 °C
- Storage Comment
- Store undiluted at 4°C. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
-
-
: "Temporal expression of VLA-2 and modulation of its ligand specificity by rat glomerular epithelial cells in vitro." in: Laboratory investigation; a journal of technical methods and pathology, Vol. 69, Issue 6, pp. 690-702, (1994) (PubMed).
-
: "Temporal expression of VLA-2 and modulation of its ligand specificity by rat glomerular epithelial cells in vitro." in: Laboratory investigation; a journal of technical methods and pathology, Vol. 69, Issue 6, pp. 690-702, (1994) (PubMed).
-
- Target
- IgG2
- Abstract
- IgG2 Products
- Synonyms
- FCGR2B Isotype Control, Fc fragment of IgG, low affinity IIb, receptor (CD32) Isotype Control, FCGR2B Isotype Control
- Target Type
- Antibody
- Background
- Synonyms: anti-KLH
-
You are here:
